Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Sees Significant Growth in Short Interest

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) was the target of a significant increase in short interest during the month of February. As of February 13th, there was short interest totaling 5,748 shares, an increase of 106.3% from the January 29th total of 2,786 shares. Based on an average daily trading volume, of 31,320 shares, the days-to-cover ratio is currently 0.2 days. Based on an average daily trading volume, of 31,320 shares, the days-to-cover ratio is currently 0.2 days.

Alpha Tau Medical Stock Down 12.2%

Shares of Alpha Tau Medical stock traded down $0.17 on Friday, reaching $1.20. The stock had a trading volume of 17,720 shares, compared to its average volume of 63,744. The company has a 50 day moving average price of $0.82 and a 200 day moving average price of $0.49. Alpha Tau Medical has a 1 year low of $0.13 and a 1 year high of $1.50.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.